Stabilization of α-conotoxin AuIB: Influences of disulfide connectivity and backbone cyclization

Antioxidants and Redox Signaling

Volumn 14, Issue 1, 2011, Pages 87-95

  Lovelace, Erica S ^a   Gunasekera, Sunithi ^a   Alvarmo, Charlotta ^a   Clark, Richard J ^a   Nevin, Simon T ^a   Grishin, Anton A ^a,b   Adams, David J ^a,b   Craik, David J ^a   Daly, Norelle L ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CONOTOXIN AUIB; AMINO ACID; CONOTOXIN; DISULFIDE; NICOTINIC RECEPTOR; SNAIL VENOM; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYCLIZATION; DEGRADATION; DISULFIDE BOND; HUMAN; ISOMER; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SNAIL;

ANIMALS; CONOTOXINS; CYCLIZATION; DISULFIDES; DRUG STABILITY; HUMANS; MALE; MODELS, MOLECULAR; RATS; RECEPTORS, NICOTINIC;

GASTROPODA; RATTUS;

EID: 78649468386     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.3068     Document Type: Article

References (35)

1. Adams DJ, Alewood PF, Craik DJ, Drinkwater RD, and Lewis RJ. Conotoxins and their potential pharmaceutical applications. Drug Dev Res 46: 219-234, 1999.
2. Andreadou I, van de Water B, Commandeur JN, Nagelkerke FJ, and Vermeulen NP. Comparative cytotoxicity of 14 novel selenocysteine se-conjugates in rat renal proximal tubular cells. Toxicol Appl Pharmacol 141: 278-287, 1996.
3. Armishaw CJ, Daly NL, Nevin ST, Adams DJ, Craik DJ, and Alewood PF. Alpha-selenoconotoxins, a new class of potent alpha7 neuronal nicotinic receptor antagonists. J Biol Chem 281: 14136-14143, 2006.
4. Armishaw CJ, Dutton JL, Craik DJ, and Alewood PF. Establishing regiocontrol of disulfide bond isomers of alpha-conotoxin ImI via the synthesis of N-to-C cyclic analogues. Biopolymers 94:307-313, 2010.
5. Azam L and McIntosh JM. Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors. Acta Pharmacol Sin 30: 771-783, 2009.
6. Brünger AT, Adams PD, and Rice LM. New applications of simulated annealing in X-ray crystallography and solution NMR. Structure 5: 325-336, 1997.
7. Brust A, Palant E, Croker DE, Colless B, Drinkwater R, Patterson B, Schroeder CI, Wilson D, Nielsen CK, Smith MT, Alewood D, Alewood PF, and Lewis RJ. chi-Conopeptide pharmacophore development: toward a novel class of nor-epinephrine transporter inhibitor (Xen2174) for pain (perpendicular). J Med Chem 52: 6991-7002, 2009.
8. Clark RJ, Fischer H, Dempster L, Daly NL, Rosengren KJ, Nevin ST, Meunier FA, Adams DJ, and Craik DJ. Engineering stable peptide toxins by means of backbone cy-clization: stabilization of the alpha-conotoxin MII. Proc Natl Acad Sci USA 102: 13767-13772, 2005.
9. Clubb RT, Ferguson SB, Walsh CT, and Wagner G. Three-dimensional solution structure of Escherichia coli periplasmic cyclophilin. Biochemistry 33: 2761-2772, 1994.
10. Daly NL, Clark RJ, Plan MR, and Craik DJ. Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif. Biochem J 393: 619-626, 2006.
11. Dutertre S and Lewis RJ. Toxin insights into nicotinic ace-tylcholine receptors. Biochem Pharmacol 72: 661-670, 2006.
12. Dutton JL, Bansal PS, Hogg RC, Adams DJ, Alewood PF, and Craik DJ. A new level of conotoxin diversity, a non-native disulfide bond connectivity in alpha-conotoxin AuIB reduces structural definition but increases biological activity. J Biol Chem 277: 48849-48857, 2002.
13. Dutton JL and Craik DJ. alpha-Conotoxins: nicotinic acetyl-choline receptor antagonists as pharmacological tools and potential drug leads. Curr Med Chem 8: 327-344, 2001.
14. Dwoskin LP and Crooks PA. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery. J Pharmacol Exp Ther 298: 395-402, 2001.
15. Eccles C, Guntert P, Billeter M, and Wü thrich K. Efficient analysis of protein 2D NMR spectra using the software package EASY. J Biomol NMR 1: 111-130, 1991.
16. Grishin AA, Wang CI, Muttenthaler M, Alewood PF, Lewis RJ, and Adams DJ. a-Conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of a3b4 nAChRs. J Biol Chem 285: 22254-22263, 2010.
17. Guntert P, Mumenthaler C, and Wüthrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol 273: 283-298, 1997.
18. Hutchinson EG and Thornton JM. PROMOTIF-a program to identify and analyze structural motifs in proteins. Protein Sci 5: 212-220, 1996.
19. Jin AH, Daly NL, Nevin ST, Wang CI, Dutertre S, Lewis RJ, Adams DJ, Craik DJ, and Alewood PF. Molecular engineering of conotoxins: the importance of loop size to alpha-conotoxin structure and function. J Med Chem 51: 5575-5584, 2008.
20. Klotz U. Ziconotide-a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain-a short review. Int J Clin Pharmacol Ther 44: 478-483, 2006.
21. Laskowski RA, Moss DS, and Thornton JM. Main-chain bond lengths and bond angles in protein structures. J Mol Biol 231: 1049-1067, 1993.
22. Livett BG, Gayler KR, and Khalil Z. Drugs from the sea: conopeptides as potential therapeutics. Curr Med Chem 11: 1715-1723, 2004.
23. Lovelace ES, Armishaw CJ, Colgrave ML, Wahlstrom ME, Alewood PF, Daly NL, and Craik DJ. Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter. J Med Chem 49: 6561-6568, 2006.
24. Luo S, Kulak JM, Cartier GE, Jacobsen RB, Yoshikami D, Olivera BM, and McIntosh JM. alpha-Conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J Neurosci 18: 8571-8579, 1998.
25. McIntosh JM, Santos AD, and Olivera BM. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annu Rev Biochem 68: 59-88, 1999.
26. Meister A and Anderson ME. Glutathione. Annu Rev Bio-chem 52: 711-760, 1983.
27. Miljanich GP. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Curr Med Chem 11: 3029-3040, 2004.
28. Millard EL, Daly NL, and Craik DJ. Structure-activity relationships of alpha-conotoxins targeting neuronal nicotinic acetylcholine receptors. Eur J Biochem 271: 2320-2326, 2004.
29. Nicke A, Loughnan ML, Millard EL, Alewood PF, Adams DJ, Daly NL, Craik DJ, and Lewis RJ. Isolation, structure, and activity of GID, a novel alpha 4=7-conotoxin with an extended N-terminal sequence. J Biol Chem 278: 3137-3144, 2003.
30. Nicke A, Samochocki M, Loughnan ML, Bansal PS, Maelicke A, and Lewis RJ. Alpha-conotoxins EpI and AuIB switch subtype selectivity and activity in native versus recombinant nicotinic acetylcholine receptors. FEBS Lett 554: 219-223, 2003.
31. Rabenstein DL and Weaver KH. Kinetics and equilibria of the thiol=disulfide exchange reactions of somatostatin with glutathione. J Org Chem 61: 7391-7397, 1996.
32. TerlauHandOlivera BM. Conus venoms:arichsourceofnovel ion channel-targeted peptides. Physiol Rev 84: 41-68, 2004.
33. 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J Biomol NMR 5: 67-81, 1995.
34. Wüthrich K. NMR of Proteins and Nucleic Acids. New York: Wiley-Interscience, 1986.
35. Yuan DD, Han YH, Wang CG, and Chi CW. From the identification of gene organization of alpha conotoxins to the cloning of novel toxins. Toxicon 49: 1135-1149, 2007.